{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T14:18:45Z","timestamp":1788013125889,"version":"build-2784847793"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s12328-025-02263-3","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T09:26:34Z","timestamp":1766136394000},"page":"274-281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cytomegalovirus-associated ulceration complicating immune checkpoint inhibitor-related colitis"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9765-5473","authenticated-orcid":false,"given":"Michiko","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiyu","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiya","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Usami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miri","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"issue":"21","key":"2263_CR1","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","volume":"372","author":"EB Garon","year":"2015","unstructured":"Garon EB, Rizvi NA, Hui RS, et al. Pembrolizumab for the treatment of non\u2013small-cell lung cancer. N Engl J Med. 2015;372(21):2018\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1501824.","journal-title":"N Engl J Med"},{"issue":"36","key":"2263_CR2","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1200\/JCO.21.01440","volume":"39","author":"BJ Schneider","year":"2021","unstructured":"Schneider BJ, Naidoo J, Santomasso BD, et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update. J Clin Oncol. 2021;39(36):4073\u2013126. https:\/\/doi.org\/10.1200\/JCO.21.01440.","journal-title":"J Clin Oncol"},{"key":"2263_CR3","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. Bethesda, MD: U.S. Department of Health and Human Services; 2017. Available from: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf"},{"issue":"1","key":"2263_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jmii.2021.10.002","volume":"55","author":"KY Liu","year":"2022","unstructured":"Liu KY, Chao HM, Lu YJ, et al. Cytomegalovirus proctitis in non-human immunodeficiency virus infected patients: a case report and literature review. J Microbiol Immunol Infect. 2022;55(1):154\u201360. https:\/\/doi.org\/10.1016\/j.jmii.2021.10.002.","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"2263_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.15171\/mejdd.2019.138","volume":"11","author":"A Sadeghi","year":"2019","unstructured":"Sadeghi A, Biglari M, Forootan M, et al. Solitary rectal ulcer syndrome: a narrative review. Middle East J Dig Dis. 2019;11(3):129\u201334. https:\/\/doi.org\/10.15171\/mejdd.2019.138.","journal-title":"Middle East J Dig Dis"},{"key":"2263_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12245-023-00578-x","volume":"17","author":"E Bae","year":"2024","unstructured":"Bae E, Tran J, Shah K. Stercoral colitis in the emergency department: a review of the literature. Int J Emerg Med. 2024;17:3. https:\/\/doi.org\/10.1186\/s12245-023-00578-x.","journal-title":"Int J Emerg Med"},{"issue":"18","key":"2263_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019836","volume":"99","author":"C Sugawa","year":"2020","unstructured":"Sugawa C, Culver A, Diebel M, et al. Acute hemorrhagic rectal ulcer: experience in 11 patients at an urban acute care center in the USA. Medicine (Baltimore). 2020;99(18):e19836. https:\/\/doi.org\/10.1097\/MD.0000000000019836.","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"2263_CR8","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.3748\/wjg.v21.i12.3750","volume":"21","author":"T Hasegawa","year":"2015","unstructured":"Hasegawa T, Aomatsu K, Nakamura M, et al. Cytomegalovirus colitis followed by ischemic colitis in a non-immunocompromised adult: a case report. World J Gastroenterol. 2015;21(12):3750\u20134. https:\/\/doi.org\/10.3748\/wjg.v21.i12.3750.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"2263_CR9","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1128611","volume":"5","author":"K Lankes","year":"2016","unstructured":"Lankes K, Hundorfean G, Harrer T, et al. Anti-TNF refractory colitis after checkpoint inhibitor therapy: possible role of CMV-mediated immunopathogenesis. Oncoimmunology. 2016;5(4):e1128611. https:\/\/doi.org\/10.1080\/2162402X.2015.1128611.","journal-title":"Oncoimmunology"},{"issue":"1","key":"2263_CR10","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.12788\/jcso.0368","volume":"16","author":"A Perry","year":"2018","unstructured":"Perry A, Walter J, Olsen S, et al. Concurrent ipilimumab and CMV colitis refractory to oral steroids. J Community Support Oncol. 2018;16(1):e30\u20133. https:\/\/doi.org\/10.12788\/jcso.0368.","journal-title":"J Community Support Oncol"},{"issue":"1","key":"2263_CR11","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/j.jtho.2019.07.026","volume":"15","author":"ST van Turenhout","year":"2020","unstructured":"van Turenhout ST, Berghuis M, Snaebjornsson P, et al. Cytomegalovirus in steroid-refractory immune checkpoint inhibition-related colitis. J Thorac Oncol. 2020;15(1):e15\u201320. https:\/\/doi.org\/10.1016\/j.jtho.2019.07.026.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"2263_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000506186","volume":"14","author":"Y Furuta","year":"2020","unstructured":"Furuta Y, Miyamoto H, Naoe H, et al. Cytomegalovirus enterocolitis in a patient with refractory immune-related colitis. Case Rep Gastroenterol. 2020;14(1):103\u20139. https:\/\/doi.org\/10.1159\/000506186.","journal-title":"Case Rep Gastroenterol"},{"issue":"6","key":"2263_CR13","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1111\/1759-7714.13401","volume":"11","author":"J Ni","year":"2020","unstructured":"Ni J, Zhang X, Zhang L. Opportunistic bowel infection after corticosteroid dosage tapering in a stage IV lung cancer patient with tislelizumab-related colitis. Thorac Cancer. 2020;11(6):1699\u2013702. https:\/\/doi.org\/10.1111\/1759-7714.13401.","journal-title":"Thorac Cancer"},{"issue":"5","key":"2263_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-233519","volume":"13","author":"KB Harris","year":"2020","unstructured":"Harris KB, Funchain P, Baggott BB. CMV coinfection in treatment refractory immune checkpoint inhibitor colitis. BMJ Case Rep. 2020;13(5):e233519. https:\/\/doi.org\/10.1136\/bcr-2019-233519.","journal-title":"BMJ Case Rep"},{"issue":"4","key":"2263_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3892\/mco.2021.2227","volume":"14","author":"Y Kadokawa","year":"2021","unstructured":"Kadokawa Y, Takagi M, Yoshida T, et al. Efficacy and safety of infliximab for steroid-resistant immune-related adverse events: a retrospective study. Mol Clin Oncol. 2021;14(4):65. https:\/\/doi.org\/10.3892\/mco.2021.2227.","journal-title":"Mol Clin Oncol"},{"key":"2263_CR16","doi-asserted-by":"publisher","first-page":"1298902","DOI":"10.3389\/fimmu.2023.1298902","volume":"14","author":"C Luo","year":"2023","unstructured":"Luo C, Chen H, Wu H, Liu Y, Li G, Lun W, et al. Case report: Toripalimab \u2013 a novel immune checkpoint inhibitor in advanced nasopharyngeal carcinoma and severe immune-related colitis. Front Immunol. 2023;14:1298902. https:\/\/doi.org\/10.3389\/fimmu.2023.1298902.","journal-title":"Front Immunol"},{"key":"2263_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2022.101794","volume":"41","author":"M Nakai","year":"2022","unstructured":"Nakai M, Kai Y, Suzuki K, et al. A case of perforated immune-related colitis complicated by cytomegalovirus infection during treatment of immune-related adverse effect in lung cancer immunotherapy. Respir Med Case Rep. 2022;41:101794. https:\/\/doi.org\/10.1016\/j.rmcr.2022.101794.","journal-title":"Respir Med Case Rep"},{"issue":"6","key":"2263_CR18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63308","volume":"16","author":"M Iwamuro","year":"2024","unstructured":"Iwamuro M, Tanaka T, Makimoto G, et al. Two cases of cytomegalovirus colitis during the treatment of immune checkpoint inhibitor\u2013associated colitis. Cureus. 2024;16(6):e63308. https:\/\/doi.org\/10.7759\/cureus.63308.","journal-title":"Cureus"},{"issue":"1","key":"2263_CR19","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000001569","volume":"12","author":"M Gautam","year":"2025","unstructured":"Gautam M, Jahagirdar V, Mahadevia H, Sanders K, Campbell JP, Sylvestre PB, et al. Double whammy: a case report of immune checkpoint inhibitor colitis and concomitant cytomegalovirus colitis in a patient on Nivolumab. ACG Case Rep J. 2025;12(1):e01569. https:\/\/doi.org\/10.14309\/crj.0000000000001569.","journal-title":"ACG Case Rep J"},{"issue":"1","key":"2263_CR20","doi-asserted-by":"publisher","DOI":"10.4110\/in.2022.22.e2","volume":"22","author":"JB Lee","year":"2022","unstructured":"Lee JB, Kim HR, Ha SJ. Immune checkpoint inhibitors in 10 years: contribution of basic research and clinical application in cancer immunotherapy. Immune Netw. 2022;22(1):e2. https:\/\/doi.org\/10.4110\/in.2022.22.e2.","journal-title":"Immune Netw"},{"issue":"11","key":"2263_CR21","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.3390\/diagnostics11111952","volume":"11","author":"Y Qin","year":"2021","unstructured":"Qin Y, Wang G, Kong D, et al. Risk factors of cytomegalovirus reactivation in ulcerative colitis patients: a meta-analysis. Diagnostics. 2021;11(11):1952. https:\/\/doi.org\/10.3390\/diagnostics11111952.","journal-title":"Diagnostics"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-025-02263-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-025-02263-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-025-02263-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:45:20Z","timestamp":1771663520000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-025-02263-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2263"],"URL":"https:\/\/doi.org\/10.1007\/s12328-025-02263-3","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest in association with the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This case report was conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki and its amendments. Ethical review was waived by the institutional review board of the Steel Memorial Muroran Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report and any accompanying images.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}